These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 15951823

  • 1. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
    Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, Reimann KA, Franchini G.
    Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B.
    Nature; 2004 Mar 11; 428(6979):182-5. PubMed ID: 15014500
    [Abstract] [Full Text] [Related]

  • 3. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J, King LR, Robert-Guroff M, Hryniewicz A, Venzon D, Meseda C, Weir J, Nalca A, Livingston V, Wells J, Lewis MG, Huggins J, Zwiers SH, Golding H, Franchini G.
    J Infect Dis; 2005 Feb 01; 191(3):372-81. PubMed ID: 15633096
    [Abstract] [Full Text] [Related]

  • 4. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD.
    J Virol; 2005 Jun 01; 79(12):7845-51. PubMed ID: 15919938
    [Abstract] [Full Text] [Related]

  • 5. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
    Nigam P, Earl PL, Americo JL, Sharma S, Wyatt LS, Edghill-Spano Y, Chennareddi LS, Silvera P, Moss B, Robinson HL, Amara RR.
    Virology; 2007 Sep 15; 366(1):73-83. PubMed ID: 17507071
    [Abstract] [Full Text] [Related]

  • 6. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT, Berhanu A, Bigger CB, Prigge J, Silvera PM, Grosenbach DW, Hruby D.
    Vaccine; 2020 Jan 16; 38(3):644-654. PubMed ID: 31677948
    [Abstract] [Full Text] [Related]

  • 7. Subunit recombinant vaccine protects against monkeypox.
    Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.
    J Immunol; 2006 Aug 15; 177(4):2552-64. PubMed ID: 16888017
    [Abstract] [Full Text] [Related]

  • 8. Smallpox vaccine safety is dependent on T cells and not B cells.
    Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G.
    J Infect Dis; 2011 Apr 15; 203(8):1043-53. PubMed ID: 21450994
    [Abstract] [Full Text] [Related]

  • 9. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Holý A, De Clercq E, Niesters HG, Fries E, Maas C, Mulder PG, van der Zeijst BA, Osterhaus AD.
    Nature; 2006 Feb 09; 439(7077):745-8. PubMed ID: 16341204
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.
    J Virol; 2004 May 09; 78(9):4433-43. PubMed ID: 15078924
    [Abstract] [Full Text] [Related]

  • 12. Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.
    Chaudhri G, Tahiliani V, Eldi P, Karupiah G.
    J Virol; 2015 Feb 09; 89(3):1889-99. PubMed ID: 25428875
    [Abstract] [Full Text] [Related]

  • 13. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.
    Wei H, Huang D, Fortman J, Wang R, Shao L, Chen ZW.
    J Virol; 2009 Jan 09; 83(2):1115-25. PubMed ID: 19004937
    [Abstract] [Full Text] [Related]

  • 14. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
    Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L, Spano YE, Silvera PM, Moss B.
    Proc Natl Acad Sci U S A; 2008 Aug 05; 105(31):10889-94. PubMed ID: 18678911
    [Abstract] [Full Text] [Related]

  • 15. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.
    Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, Glidewell J, Ahmed R, Amara R, Damon IK.
    Clin Vaccine Immunol; 2007 Oct 05; 14(10):1318-27. PubMed ID: 17715329
    [Abstract] [Full Text] [Related]

  • 16. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
    Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.
    Vaccine; 2010 Sep 14; 28(40):6627-36. PubMed ID: 20659519
    [Abstract] [Full Text] [Related]

  • 17. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.
    Marriott KA, Parkinson CV, Morefield SI, Davenport R, Nichols R, Monath TP.
    Vaccine; 2008 Jan 24; 26(4):581-8. PubMed ID: 18077063
    [Abstract] [Full Text] [Related]

  • 18. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS.
    J Virol; 2004 Nov 24; 78(22):12471-9. PubMed ID: 15507634
    [Abstract] [Full Text] [Related]

  • 19. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
    Iizuka I, Ami Y, Suzaki Y, Nagata N, Fukushi S, Ogata M, Morikawa S, Hasegawa H, Mizuguchi M, Kurane I, Saijo M.
    Jpn J Infect Dis; 2017 Jul 24; 70(4):408-415. PubMed ID: 28003603
    [Abstract] [Full Text] [Related]

  • 20. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.
    Virology; 2005 Sep 01; 339(2):164-75. PubMed ID: 15993917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.